Course

Lowering Insulin Resistance: The Key to Treating Obesity

Presented by Morgan Nolte, PT, DPT, Board-Certified Geriatric Clinical Specialist

Access Pass Member Exclusive

Course Description

This presentation explains the link between insulin resistance and obesity. You will learn about the major causes of insulin resistance, symptoms, screening, and testing measures. You will have clarity about why insulin resistance is at the root cause of many conditions including obesity, type 2 diabetes, heart disease, dementia, osteoarthritis, and more.
This content is only available to members.
AdultOTPTSLPDiabetes

Meet Your Presenter

Morgan Nolte, PT, DPT is a board -certified clinical specialist in geriatric physical therapy. Frustrated by a lack of preventative care that focused on reversing risk factors instead of just treating symptoms, Dr. Nolte founded Zivli, LLC- an online course and coaching program that helps adults reverse insulin resistance for long-term weight loss and disease prevention. Zivli serves as a bridge between busy physicians and their patients by offering detailed education and ongoing behavioral support needed to change health habits for good.

Accreditation

  • This course has been Approved by CERS, an Approval Agency for the California Board of Physical Therapy. CERS Course Approval #: 22-50840-1

Course Details

Learning Objectives

Upon completion of this course, participants will be able to:

  1. Discuss the prevalence of obesity.
  2. Describe how insulin resistance is the root cause of obesity.
  3. Describe signs of insulin resistance across the lifespan.
  4. Explain how insulin resistance contributes to HTN, dementia, diabetes, cancer, OP, sarcopenia, arthritis, and more.
  5. Explain how age, sex, genetics, medications, and different lifestyle components affect insulin.

Time-ordered Agenda

  • 0:00 - Why the rise in obesity and severe obesity since 1977?
  • 0:10 - What causes obesity…insulin or calories?
  • 0:20 - The hypothalamus, hunger and weight regulation
  • 0:30 - What is insulin resistance?
  • 0:40 - Signs and symptoms of insulin resistance
  • 0:50 - Q&A
  • 1:00 - End course + quiz

Instructional Level

Introductory
Information is geared to practitioners with little or no knowledge of the subject matter. Focus is on providing general introductory information.

Target Audience

PTs, OTs, and SLPs that work with adults (and likely themselves and their parents).

Live Course Information

This course will be presented on the Zoom platform. High-speed internet connection is required.

Recorded Course Information

This course will be available for PT CEUs until March 21, 2023.

Instructor Financial Disclosures

  • Presenter is being paid by Therapy Insights to prepare and present this course.

Instructor Non-financial Disclosures

  • None.

Certificates of Completion

Once the exam is completed and you have provided feedback about the course, you will receive an emailed certificate of completion with course title, course instructor name/title, learning objectives, your name, your license number (if desired), and a confirmation from the CE Task Force director confirming completion of course. If your state licensing board requires specific records of course participation (all licensing boards are different), please email us and we will provide the documentation.

Instructional Methodology

Lecture

Refunds & Cancellation

Please see our full refund and cancellation policies here.

Complete the Course

Want access to this course (and much more)? Add CEUs/Courses to your Access Pass.

Create or modify your custom Access Pass subscription to get instant and easy access to handouts, therapy materials, clinical tools, research summaries, and continuing education courses so that you can spend your valuable time doing what you do best: Connecting with your patients and changing lives for the better.

Use code
NOLTE
to get $10 off of your first month and support this presenter's work.
Subscribe to CEUs/Courses

Already subscribed to CEUs/Courses? Log in to access this member exclusive.